SCHEMBL2238965

SCHEMBL2238965

O=P(O)(O)OC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2149479 0.88 INPP5A (0.52)
SCHEMBL2238021 0.88
SCHEMBL25019698 0.87 INPP5A (0.52)
Ammonia Solution, Strong SCHEMBL27869061 0.86 INPP5A (0.50)
SCHEMBL15106222 0.86 INPP5A (0.50)
SCHEMBL7041102 0.86 INPP5A (0.50)
SCHEMBL15105636 0.86 INPP5A (0.50)
SCHEMBL14412710 0.86 INPP5A (0.50)
SCHEMBL342838 0.86 INPP5A (0.50)
SCHEMBL10768790 0.84 INPP5A (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4413138-A1 COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2024-08-14 EP claimed
WO-2023064707-A1 COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION IONIS PHARMACEUTICALS, INC. (US) 2023-04-20 WO claimed
US-20060172201-A1 Non-aqueous electrolyte and lithium secondary battery using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2006-08-03 US claimed
EP-1357628-A1 NONAQUEOUS ELECTROLYTIC LIQUIDS AND LITHIUM SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2003-10-29 EP claimed
WO-2025047679-A1 STABLE TARGET EDITING GUIDE RNA HAVING PHOSPHATE MOIETY MODIFICATION INTRODUCED THEREINTO 学校法人福岡大学 2025-03-06 WO disclosed
CN-119213123-A LPA inhibitors and uses thereof 厦门甘宝利生物医药有限公司 2024-12-27 CN disclosed
EP-4413138-A1 COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2024-08-14 EP disclosed
EP-4402260-A1 COMPOUNDS AND METHODS FOR REDUCING DNM1L OR DRP1 EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2024-07-24 EP disclosed
CN-118256495-A Modified double-stranded oligonucleotide molecules and uses thereof 北京炫景瑞医药科技有限公司 2024-06-28 CN disclosed
CN-114703184-B LPA inhibitors and uses thereof 厦门甘宝利生物医药有限公司 2024-06-18 CN disclosed
EP-4355338-A1 COMPOUNDS AND METHODS FOR REDUCING IFNAR1 EXPRESSION Ionis Pharmaceuticals, Inc. (US) 2024-04-24 EP disclosed
EP-4355429-A1 TREATMENT OF MST1 RELATED DISEASES AND DISORDERS EMPIRICO INC. (US) 2024-04-24 EP disclosed
US-20090253045-A1 NONAQUEOUS ELECTROLYTIC SOLUTIONS AND NONAQUEOUS-ELECTROLYTE BATTERIES MITSUBISHI CHEMICAL CORPORATION (JP) 2009-10-08 US disclosed
EP-2031689-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY Mitsubishi Chemical Corporation (JP) 2009-03-04 EP disclosed
CN-1956706-A Bisphosphonate enteric solid oral dosage form comprising a chelating agent PROCTER & GAMBLE (US) 2007-05-02 CN disclosed
CN-1427882-A Liquid detergent compositions PROCTER & GAMBLE (US) 2003-07-02 CN disclosed
CN-86105989-A POLYOLEFIN COMPOSITIONS 1988-02-17 CN disclosed
EP-0009385-B1 PROCESS FOR METHANOL PRODUCTION MONSANTO COMPANY (US) 1983-01-05 EP disclosed
EP-0009385-A1 Process for methanol production MONSANTO COMPANY (US) 1980-04-02 EP disclosed
US-4181675-A FROM HYDROGEN AND CARBON DIOXIDE-CONTAINING SYNTHESIS GAS, SEPARATING PURGE GAS WITH PERSELECTIVE HOLLOW FIBER MEMBRANE MONSANTO COMPANY (US) 1980-01-01 US disclosed